Cannara Biotech Financial Overview
Cannara Biotech's market cap is currently $154.52M. The company's EPS TTM is C$0.04; its P/E ratio is 9.86; Cannara Biotech is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
